The reports you linked measure "access and equity and outcomes" - i.e., averaged cost-effectiveness for people who rely on popular insurance programs, rather than paying out of pocket.
US scores poorly in those due to high sticker prices; the quality available for those who can afford is the best in US; both for specialist rare cases and for mundane cases.